1-6 of 6
Mohsen Karimi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Jakob Werner Hansen, MD, Morten Munk Johansen, MD, Maj Karoline Westman, MSc, Leonie Saft, MD PhD, Lene Dissing Sjö, MD PhD, Claus Werenberg Marcher, MD PhD, Mette Skov Holm, MD PhD, Marios Dimitriou, PhD, Mohsen Karimi, PhD, Klas Raaschou-Jensen, MD, Andreas Birkedal Glenthøj, MD PhD, Marianne Tang Severinsen, MD PhD, Eva Hellström-Lindberg, MD PhD, Mette Klarskov Andersen, MD DMSc, Kirsten Grønbæk, Professor, MD DMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 794.
https://doi.org/10.1182/blood-2018-99-110767
Published: 2018
Journal Articles

Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML

Andreas T Björklund, MD PhD MSc, Mattias Carlsten, MD PhD, Ebba Sohlberg, PhD, Trevor Clancy, Lisa Liu, Mohsen Karimi, PhD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Emma Watz, Björn Engelbrekt Wahlin, Marzia Palma, MD PhD, Lotta Hansson, Per Ljungman, Eva Hellstrom-Lindberg, MD PhD, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4458.
https://doi.org/10.1182/blood.V130.Suppl_1.4458.4458
Published: 2017
Journal Articles

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Luca Malcovati, MD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Ilaria Ambaglio, MD, Martin Jadersten, MDPhD, Monika Jansson, Chiara Elena, MD, Anna Gallì, PhD, Gunilla Walldin, MD, Matteo G Della Porta, MD, Klas Raaschou-Jensen, MD, Erica Travaglino, Klaus Kallenbach, MD PhD, Viktor Ljungstrom, Emanuela Boveri, MD, Rosangela Invernizzi, MD, Richard Rosenquist, MD PhD, Peter J. Campbell, PhD, Mario Cazzola, MD, Eva Hellstrom-Lindberg
Journal: Blood
Blood (2014) 124 (21): 825.
https://doi.org/10.1182/blood.V124.21.825.825
Published: 2014
Journal Articles

Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation

Simona Conte, Liselotte Vesterlund, PhD, Shintaro Katayama, PhD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Monika Jansson, Teresa Mortera-Blanco, PhD, Marios Dimitriou, PhD, Birgitta Sander, MD, PhD, Tiina Skoog, Peter J. Campbell, PhD, Juha Kere, MD, PhD, Per Unneberg, PhD, Eva Hellström-Lindberg, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2408.
https://doi.org/10.1182/blood.V122.21.2408.2408
Published: 2013
Journal Articles

Hierarchical Analysis Of Recurrent Point Mutations In SF3B1 and TET2 In RARS Stem Cells

Teresa Mortera-Blanco, PhD, Marios Dimitriou, PhD, Petter Woll, PhD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Simona Conte, Oni Chowdhuri, Monika Jansson, Peter J. Campbell, PhD, Sten Eirik W Jacobsen, PhD, Eva Hellström-Lindberg, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2749.
https://doi.org/10.1182/blood.V122.21.2749.2749
Published: 2013
Journal Articles

Allelic Methylation Levels of VTRNA2-1 Predict Outcome in Higher Risk MDS Patients Not Treated by Azacytidine.

Marianne B. Treppendahl, MD, Magnus Tobiasson, MD, Anni Aggerholm, PhD, Mohsen Karimi, PhD, Trine Silkjaer, MD, Lone S. Friis, MD, PhD, Mette K. Andersen, PhD, Lars Kjeldsen, MD, PhD, Mette S. Holm, MD, PhD, Eva Hellström-Lindberg, PhD, Kirsten Grønbæk, MD, DMSc
Journal: Blood
Blood (2012) 120 (21): 2394.
https://doi.org/10.1182/blood.V120.21.2394.2394
Published: 2012